ロード中...
PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with an extremely poor prognosis. There is an urgent need to identify new therapeutic targets and also understand the mechanism of PDAC progression that leads to aggressiveness of the disease. To find therapeutic targets, we analyzed da...
保存先:
| 出版年: | Transl Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229293/ https://ncbi.nlm.nih.gov/pubmed/32422575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100776 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|